Association between systemic inflammatory response index and glaucoma incidence from 2005 to 2008
Frontiers in Medicine · 04.02.2025 · 12
DOI: 10.3389/fmed.2025.1542073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 04.02.2025. Verfasst von Xiang Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Eye Institute and Affiliated Xiamen Eye Center, School of Medicine, Xiamen University, Xiamen, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study aimed to investigate the association between the Systemic Inflammatory Response Index (SIRI) and glaucoma using data from the 2005–2008 National Health and Nutrition Examination Survey (NHANES).
Methods
We performed a cross-sectional analysis using data from NHANES (2005–2008). Among participants who underwent non-mydriatic retinal imaging and Frequency Doubling Technology (FDT) visual field testing, 4,514 were included after excluding those with missing key variable data. SIRI and other inflammatory indices, including the systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR), and neutrophil-to-lymphocyte ratio (NLR), were calculated from blood samples. Logistic regression models were employed to assess the relationship between these indices and glaucoma, adjusting for demographic and health-related variables.
Results
A significant positive association was found between elevated log 2 SIRI levels and the prevalence of glaucoma (Model 3: OR 1.24, 95% CI 1.07–1.44, p < 0.005). We performed an in-depth analysis of the Log 2 SIRI quartiles and found a significant association between Log 2 SIRI Q4 and the occurrence of glaucoma (Model 3: OR1.62, 95%CI 1.12–2.34, p = 0.011). This correlation was further validated using the area under the receiver operator characteristic curve (AUC) in Model 3(AUC = 0.674).
Conclusion
Elevated SIRI levels are significantly associated with the prevalence of glaucoma, highlighting the potential role of systemic inflammation in glaucoma pathogenesis. SIRI may serve as a useful biomarker for identifying individuals at risk of glaucoma, facilitating early detection and targeted intervention strategies. Further research is needed to validate these findings and explore their clinical applications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Eye Institute and Affiliated Xiamen Eye Center, School of Medicine, Xiamen University, Xiamen, China.
- Chongqing Key Laboratory of Development and Utilization of Genuine Medicinal Materials in Three Gorges Reservoir Area, Chongqing Three Gorges Medical College, Wanzhou, China.
- Guangzhou University of Chinese Medicine, Guangzhou, China.
- Department of Pharmacy, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, China.
Zitieren
APA
Li, X., Sun, Y. Q., Zhong, X. D., Zhang, Z. J., Tang, J. F., & Luo, Z. Y. (2025). Association between systemic inflammatory response index and glaucoma incidence from 2005 to 2008. Frontiers in Medicine, 12. https://doi.org/10.3389/fmed.2025.1542073
Vancouver
Li X, Sun YQ, Zhong XD, Zhang ZJ, Tang JF, Luo ZY. Association between systemic inflammatory response index and glaucoma incidence from 2005 to 2008. Frontiers in Medicine. 2025;12. doi:10.3389/fmed.2025.1542073
BibTeX
@article{Li2025,
author = {Li, Xiang and Sun, Yi Qing and Zhong, Xiao Dan and Zhang, Zhi Jie and Tang, Jia Feng and Luo, Zhan Yang},
title = {Association between systemic inflammatory response index and glaucoma incidence from 2005 to 2008},
journal = {Frontiers in Medicine},
year = {2025},
volume = {12},
doi = {10.3389/fmed.2025.1542073}
}
EUVIMED